Michael K. Hehir - Concepedia

Author

Michael K. Hehir

Also Known As

James Wymer, M.K. Hehir, Maria E Farrugia, Michael Hehir, Michael K Hehir, Michael K. Hehir, Muppidi, Srikanth, Rup Tandan

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Vermont University at Buffalo, State University of New York University of North Carolina at Chapel Hill Duke University Harvard University

About

Michael K. Hehir is an author at University of Vermont specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.4K
2	Arts	1	1	11
3	Management	1	1	11
4	Geriatrics	1	1	13
5	Health Law	1	1	11

Michael K. Hehir

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study James F. Howard, Kimiaki Utsugisawa, Michael Benatar, The Lancet Neurology Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade	2017	745
Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial Reza Adib, John Anderson, M Handley Ashken, Kent Academic Repository (University of Kent) Immediate VersusUrologySurgical OncologyInitial ResultsGenitourinary Cancer	1997	552
Rituximab as treatment for anti-MuSK myasthenia gravis Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar, Neurology	2017	243
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic Saiju Jacob, Srikanth Muppidi, Amanda C. Guidon, Journal of the Neurological Sciences	2020	154
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial Michael Benatar, Michael McDermott, Donald B. Sanders, Muscle & Nerve	2015	139
Mycophenolate mofetil in AChR‐antibody‐positive myasthenia gravis: Outcomes in 102 patients Michael K. Hehir, Ted M. Burns, Joshua Alpers, Muscle & Nerve	2010	127
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis Katherine Clifford, Lisa D. Hobson‐Webb, Michael Benatar, Muscle & Nerve	2018	82
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi, Neurology	2020	74
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study Pushpa Narayanaswami, Donald B. Sanders, Laine Thomas, The Lancet Neurology Mycophenolate MofetilClinical EpidemiologyClinical TrialsPharmacologyPharmacotherapy	2024	44
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (<scp>MG‐CE</scp>) Amanda C. Guidon, Srikanth Muppidi, Richard J. Nowak, Muscle & Nerve	2021	37

Page 1